DE68918392D1 - Glycosyliertes Interleukin-2 enthaltende Medikamente. - Google Patents

Glycosyliertes Interleukin-2 enthaltende Medikamente.

Info

Publication number
DE68918392D1
DE68918392D1 DE68918392T DE68918392T DE68918392D1 DE 68918392 D1 DE68918392 D1 DE 68918392D1 DE 68918392 T DE68918392 T DE 68918392T DE 68918392 T DE68918392 T DE 68918392T DE 68918392 D1 DE68918392 D1 DE 68918392D1
Authority
DE
Germany
Prior art keywords
medicines containing
glycosylated interleukin
containing glycosylated
interleukin
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68918392T
Other languages
English (en)
Other versions
DE68918392T2 (de
Inventor
Willem Roskam
Bertrand Basuyaux
Pascual Ferrara
Martine Laporte
Thierry Maureaud
Natalio Vita
Alain Bayol
Genevieve Perry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Elf Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8813865A external-priority patent/FR2638969A1/fr
Application filed by Elf Sanofi SA filed Critical Elf Sanofi SA
Application granted granted Critical
Publication of DE68918392D1 publication Critical patent/DE68918392D1/de
Publication of DE68918392T2 publication Critical patent/DE68918392T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE68918392T 1988-10-21 1989-10-23 Glycosyliertes Interleukin-2 enthaltende Medikamente. Expired - Fee Related DE68918392T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8813865A FR2638969A1 (fr) 1988-10-21 1988-10-21 Procede d'isolement d'interleukine-2
FR8905150A FR2639232A1 (fr) 1988-10-21 1989-04-18 Medicaments contenant une interleukine-2 glycosylee

Publications (2)

Publication Number Publication Date
DE68918392D1 true DE68918392D1 (de) 1994-10-27
DE68918392T2 DE68918392T2 (de) 1995-05-04

Family

ID=26226948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918392T Expired - Fee Related DE68918392T2 (de) 1988-10-21 1989-10-23 Glycosyliertes Interleukin-2 enthaltende Medikamente.

Country Status (6)

Country Link
EP (2) EP0366532B1 (de)
AT (1) ATE111741T1 (de)
CA (2) CA2001108A1 (de)
DE (1) DE68918392T2 (de)
FR (1) FR2639232A1 (de)
WO (2) WO1990004406A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
EP0570493B1 (de) * 1991-02-08 2000-01-05 Diatide, Inc. Technetium-99m markierte Polypeptide zur Bildformung
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
ES2150945T3 (es) * 1992-05-21 2000-12-16 Diatide Inc Peptidos marcados con tecnecio-99m para obtencion de imagenes de trombos.
EP0665853B1 (de) * 1992-10-02 2002-08-14 Diatide, Inc. Multimerische mehrzweckwirkstoffe gegen thrombose
JP3901214B2 (ja) * 1994-09-21 2007-04-04 株式会社カネカ インターロイキン類の吸着剤，吸着除去方法および吸着器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675383A (en) * 1983-11-15 1987-06-23 The Salk Institute For Biological Studies Purification of T-cell growth factor
EP0149551A3 (de) * 1984-01-16 1987-09-23 Genentech, Inc. Synergistische Gamma-Interferon-Interleukin-2-Zusammensetzungen und Verfahren zur Herstellung desselben
EP0211835B1 (de) * 1984-03-28 1990-01-03 Cetus Corporation Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2
DE3583880D1 (de) * 1984-04-09 1991-10-02 Takeda Chemical Industries Ltd Stabile interleukin-2-zusammensetzung.
EP0172619A1 (de) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Transformand und dessen Verwendung
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
DE3621828A1 (de) * 1986-06-28 1988-01-14 Biotest Pharma Gmbh Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
DE3787805T2 (de) * 1986-08-04 1994-02-10 Garvan Inst Med Res Serumfreies gewebekulturmedium, das ein polymerzellenschutzmittel enthält.
IL83350A0 (en) * 1986-08-13 1987-12-31 Takeda Chemical Industries Ltd Pharmaceutical compositions comprising interleukin and intterferon active substances
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Also Published As

Publication number Publication date
DE68918392T2 (de) 1995-05-04
FR2639232A1 (fr) 1990-05-25
EP0366532B1 (de) 1994-09-21
EP0368711A1 (de) 1990-05-16
CA2001108A1 (fr) 1990-04-21
WO1990004642A1 (fr) 1990-05-03
WO1990004406A1 (fr) 1990-05-03
CA2001107A1 (fr) 1990-04-21
ATE111741T1 (de) 1994-10-15
EP0366532A1 (de) 1990-05-02

Similar Documents

Publication Publication Date Title
DE68923255T3 (de) Synthese von Methylaluminoxanen.
FR2519864B1 (fr) Composition huileuse a base de medicaments antitumoraux
ES2038215T3 (es) Medicamentos.
NO860854L (no) Fleksibel produksjons-stigeroermontasje.
DE3783880D1 (de) Strukturierte kolonnenpackung.
NO860665L (no) Syntesegass.
AU6102686A (en) Production of ethers from linear olefins
DE3688289D1 (de) Beweglicher tisch.
DE3575072D1 (de) Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2.
NO871939L (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
DE68918392D1 (de) Glycosyliertes Interleukin-2 enthaltende Medikamente.
MX169462B (es) Empaque principal con anillo superior de funcionamiento de viga
IT1209896B (it) Antibiotico bmg162-af2 procedimento per la sua produzione e medicinale antitumorale contenente il suddetto antibiotico come ingrediente attivo
AU7981687A (en) Factor viii-c analogs
IT1200385B (it) Fluidi a struttura oxetanica aventi migliorate caratteristiche per applicazioni speicali
IT1191622B (it) Composto antibiotico antitumorale a base di depsiptide ciclico
IT1185212B (it) Trasmettitore di pressioni di fluidi per atmosfere potenzialmente esplosive
IT8567101A1 (it) Impianto per il collegamento di dispositivi sensori con dispositivi attuatori.
AU1768188A (en) Pharmaceutical compositions
FI873707A0 (fi) Nya, -substituerade ketontronderivat.
IT1183037B (it) Collettore-deviatore per fluidi con asse di derivazione orientabile
DK44586A (da) Talesyntesemodul
IT8520156A0 (it) Procedimento per la produzione di articoli termoformati.
SE8505766L (sv) Rodiumkatalysator och anvendning derav
IL78074A0 (en) Production of interleukin-2

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI, PARIS, FR

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8339 Ceased/non-payment of the annual fee